Bioventus Inc (BVS)
3.97
+0.01
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
3.98
+0.01
(+0.25%)
Pre-Market: 20:00
Bioventus Price to Book Value: 1.460 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.460 |
| May 02, 2024 | 1.456 |
| May 01, 2024 | 1.467 |
| April 30, 2024 | 1.456 |
| April 29, 2024 | 1.496 |
| April 26, 2024 | 1.463 |
| April 25, 2024 | 1.496 |
| April 24, 2024 | 1.526 |
| April 23, 2024 | 1.585 |
| April 22, 2024 | 1.577 |
| April 19, 2024 | 1.647 |
| April 18, 2024 | 1.673 |
| April 17, 2024 | 1.728 |
| April 16, 2024 | 1.706 |
| April 15, 2024 | 1.702 |
| April 12, 2024 | 1.668 |
| April 11, 2024 | 1.756 |
| April 10, 2024 | 1.815 |
| April 09, 2024 | 1.847 |
| April 08, 2024 | 1.902 |
| April 05, 2024 | 1.847 |
| April 04, 2024 | 1.80 |
| April 03, 2024 | 1.833 |
| April 02, 2024 | 1.840 |
| April 01, 2024 | 1.906 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.898 |
| March 27, 2024 | 1.884 |
| March 26, 2024 | 1.877 |
| March 25, 2024 | 1.873 |
| March 22, 2024 | 1.986 |
| March 21, 2024 | 1.982 |
| March 20, 2024 | 2.099 |
| March 19, 2024 | 1.972 |
| March 18, 2024 | 2.004 |
| March 15, 2024 | 1.990 |
| March 14, 2024 | 1.895 |
| March 13, 2024 | 1.931 |
| March 12, 2024 | 2.045 |
| March 11, 2024 | 1.939 |
| March 08, 2024 | 1.972 |
| March 07, 2024 | 2.015 |
| March 06, 2024 | 1.884 |
| March 05, 2024 | 1.866 |
| March 04, 2024 | 1.796 |
| March 01, 2024 | 1.789 |
| February 29, 2024 | 1.690 |
| February 28, 2024 | 1.731 |
| February 27, 2024 | 1.80 |
| February 26, 2024 | 1.811 |
| February 23, 2024 | 1.742 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2317
Minimum
Mar 29 2023
6.536
Maximum
Nov 03 2021
2.121
Average
1.542
Median
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 14.13 |
| Retractable Technologies Inc | 0.3294 |
| Xtant Medical Holdings Inc | 2.156 |
| Asensus Surgical Inc | 1.962 |
| Catheter Precision Inc | 0.2001 |
Price to Book Value Related Metrics
| PS Ratio | 0.4855 |
| Price to Free Cash Flow | 31.16 |
| Price | 3.97 |
| Earnings Yield | -63.22% |
| Market Cap | 253.40M |
| Operating PE Ratio | 122.77 |